Cannabinoid Medicines

Private biopharma company People Science raised $5.3 million in its second seed round, which was led by Acre Venture Partners and followed by Bluestein Ventures, THIA Ventures and FORM Life Ventures. The company, which now has a total $8.5 million of seed funding, will use the latest capital to...

Emerald Health Pharmaceuticals Inc. (EHP) is launching a new financing round under its Regulation A offering. The round will open on Monday, Dec. 7, and expire on Mar. 28, 2021, or upon raising roughly $17 million, which is the maximum amount to be raised, the Sand Diego biotech company said....

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a developer of cannabinoid prescription medicines, saw its stock surge Monday after the company reported positive results from a clinical study. Wall Street took notice with some firms reaffirming their bullish stance on the stock and placing price...